Sirtex can't explain share surge

By Ruth Beran
Tuesday, 23 August, 2005

Sirtex Medical (ASX:SRX) has been asked by the ASX to explain why its share price soared from $1.90 on August 15 to $2.45 on August 22.

The company responded to the speeding ticket by saying that it is unaware of any information that has not been announced which could explain the recent trading.

Sirtex also indicated that while its financial results have not yet been audited or considered by the directors, based on its draft financial statements the company's operating loss before abnormal items and tax will be greater by more than 15 per cent for the year ended June 30, 2005 than the loss it suffered in the previous corresponding year.

At the time of writing, Sirtex shares were trading at $2.29.

Related News

Novel antibiotic activates 'suicide' mechanism in superbug

Researchers have discovered a new class of antibiotic that selectively targets Neisseria...

Modifications in the placenta linked to psychiatric disorders

Schizophrenia, bipolar disorder and major depression disorder are the neuropsychiatric disorders...

ADHD may be linked with an increased risk of dementia

An adult brain affected by attention deficit hyperactivity disorder (ADHD) presents modifications...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd